Tumor Angiogenesis Markers

Eppenberger U, Kueng W, Schlaeppi JM, et al. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 1998 16 3129-3136. 

Table 5. Effects of EPA ethylester and EPAD on apoptotic cell number, CD34 (an angiogenesis marker) expression, CDS-, and NK-positive cell numbers in tumors of mice with subcutaneously implanted LLC ...

As shown in Table (13) , The reduction of the lymphocyte, CD4 and CD8 T cell numbers in LLC-bearing mice was also inhibited by the oral administration of A-l (30 and/or 300 mg/kg). From the immunohistochemical analysis in tumors, A-l (30, 100 and 300 mg/kg) increased the number of apoptotic cells in the tumors. In the untreated LLC-bearing mice, von Willebrand factor (vWF, a marker of angiogenesis) expression was increased in the tumors. Angiogenesis in the tumors was inhibited by the oral administration of A-l. 

Ebbinghaus, C., Scheuermann, J., Neri, D., and Elia, G. (2004) Diagnostic and therapeutic applications of recombinant antibodies targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis, Curr Pharm Des 10, 1537-1549. 

Tubulin polymerization inhibitor 1172 Tumor angiogenesis 1278 Tumor associated antigen (TAA) 183 Tumor-associated glycoprotein 72, 1276 Tumor cell, targeting markers on 1276 Tumor growth index 523 Tumor hypoxia, assessment of 1263 Tumor necrosis factor (TN F) 7, 80, 264,... 

---